From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor

Turner, LD, Trinh, CH orcid.org/0000-0002-5087-5011, Hubball, RA et al. (5 more authors) (2022) From Fragment to Lead: De Novo Design and Development toward a Selective FGFR2 Inhibitor. Journal of Medicinal Chemistry, 65 (2). pp. 1481-1504. ISSN 0022-2623

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2021 The Authors. Published by American Chemical Society. Available under licence Creative Commons Attribution (v4).

Dates:
  • Published: 27 January 2022
  • Published (online): 15 November 2021
  • Accepted: 26 October 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Engineering & Physical Sciences (Leeds) > School of Chemistry (Leeds)
The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds) > Plant Cell & Cellular Biology (Leeds)
The University of Leeds > Faculty of Biological Sciences (Leeds) > School of Molecular and Cellular Biology (Leeds) > Synthetic Biology (Leed)
Funding Information:
Funder
Grant number
Cancer Research UK
C6228/A12512
Yorkshire Cancer Research
L376PA
Depositing User: Symplectic Publications
Date Deposited: 01 Nov 2021 15:19
Last Modified: 18 Jul 2022 16:16
Status: Published
Publisher: American Chemical Society
Identification Number: 10.1021/acs.jmedchem.1c01163
Open Archives Initiative ID (OAI ID):

Export

Statistics